Kappa-receptor mechanisms in synaptosomal Ca uptake.

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• Opioid receptors are critical targets for pain management and other neurological functions.
• Understanding the specific receptor subtypes (mu, delta, kappa) involved in opioid action is essential for developing targeted therapeutics.
• Calcium (Ca) uptake is a key cellular process modulated by various signaling pathways, including those involving opioid receptors.

Purpose of the Study:

• To investigate the effect of specific opioids on calcium uptake in rat brain synaptosomes.
• To determine the receptor subtype selectivity of opioid-induced inhibition of Ca uptake.
• To elucidate the relationship between opioid affinity, intrinsic activity, and their functional effects at kappa-receptors.

Main Methods:

• Utilized rat brain synaptosomes to measure Ca uptake in the presence of various opioids.
• Determined the potency order of different opioids, including dynorphin A 1-13, nalorphine, nalorphine epoxide, and morphine, for Ca uptake inhibition.
• Assessed the binding affinities of opioids using competition inhibition curves with a kappa-selective ligand, [3H]ethylketo-cyclazocine.
• Compared potency orders derived from Ca uptake inhibition and receptor binding assays.

Main Results:

• Dynorphin A 1-13, a kappa-selective agonist, demonstrated the highest potency in inhibiting Ca uptake, followed by nalorphine, nalorphine epoxide, and morphine.
• Morphiceptin (mu-selective) and DADLE (delta-selective) agonists did not affect Ca uptake, indicating a lack of mu or delta receptor involvement.
• pA2 values for naloxone against the tested opioids were similar, suggesting a common site of action.
• Potency orders from Ca uptake inhibition and [3H]ethylketo-cyclazocine binding assays showed discrepancies, highlighting the roles of both affinity and intrinsic activity.

Conclusions:

• The results strongly suggest that the observed inhibition of Ca uptake by these opioids occurs primarily at kappa-receptors.
• The differing potency orders indicate that both receptor affinity and intrinsic activity are crucial determinants of opioid agonistic activity at kappa-receptors.
• This study provides insights into the differential mechanisms of opioid action at specific receptor subtypes, with implications for understanding opioid pharmacology.